Top

Exploratory Phase II Multicenter, Open-Label, Clincal Trial of ST266, a Novel Secretome for Treatment of Persistent Corneal Epithelial Defects

7 January 2022

Jeng, Bennie H., Hamrah, Pedram. Kirshner, Ziv Z., Mendez, Benjamin C., Wessel, Howard C., Brown, Larry R., Steed, David L. (January 2022).

Exploratory Phase II Multicenter, Open-Label, Clinical Trial of ST266, a Novel Secretome for Treatment of Persistent Corneal Epithelial Defects. Translational Vision Science & Technology January 2022 Volume 11 No 1 Article 8.

Full publication here.